源语言 | 英语 |
---|---|
页(从-至) | 1799-1800 |
页数 | 2 |
期刊 | The Lancet |
卷 | 398 |
期 | 10313 |
DOI | |
出版状态 | 已出版 - 11月 13 2021 |
已对外发布 | 是 |
!!!ASJC Scopus Subject Areas
- 一般医学
联合国可持续发展目标
此成果有助于实现下列可持续发展目标:
访问文件
其它文件与链接
引用此
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
在: The Lancet, 卷 398, 号码 10313, 13.11.2021, 页码 1799-1800.
科研成果: 期刊稿件 › 快报 › 同行评审
}
TY - JOUR
T1 - Characteristics and risk of COVID-19-related death in fully vaccinated people in Scotland
AU - Grange, Zoe
AU - Buelo, Audrey
AU - Sullivan, Christopher
AU - Moore, Emily
AU - Agrawal, Utkarsh
AU - Boukhari, Khaled
AU - McLaughlan, Iain
AU - Stockton, Diane
AU - McCowan, Colin
AU - Robertson, Chris
AU - Sheikh, Aziz
AU - Murray, Josephine L.K.
N1 - Funding Information: ZG, AB, and CS contributed equally. AS and JLKM contributed equally. AS and CR are members of the Scottish Government Chief Medical Officer's COVID-19 Advisory Group. AS is a member of the NERVTAG Risk Stratification Subgroup and an unfunded member of AstraZeneca's COVID-19 strategic consultancy group, the Thrombocytopenia Taskforce. CM reports research funding from the Medical Research Council, Health Data Research UK, National Institute for Health Research, and the Scottish Chief Science Office. CR is a member of the Scientific Pandemic Influenza Group on Modelling and the Medicines and Healthcare products Regulatory Agency COVID-19 Vaccine Benefit and Risk Working Group. JLKM is a member of the COVID Scottish National Incident Management Team. All other authors report no competing interests. EAVE II is funded by the Medical Research Council with the support of BREATHE, the health data research hub for respiratory health, which is funded through the UK Research and Innovation Industrial Strategy Challenge Fund and delivered through Health Data Research UK. Additional support was provided through Public Health Scotland and the Scottish Government Director-General Health and Social Care. The research for this Correspondence is part of the Data and Connectivity National Core Study, led by Health Data Research UK in partnership with the Office for National Statistics and funded by UK Research and Innovation. We thank Dave Kelly from Albasoft for support with making primary care data available and James Pickett, Wendy Inglis-Humphrey, Vicky Hammersley, Maria Georgiou, Laura Gonzalez Rienda, Pam McVeigh, Amanda Burridge, Sumedha Asnani-Chetal, and Afshin Dastafshan for project management and administration support. We acknowledge the support of the EAVE II Patient Advisory Group. UA and CM acknowledge funding from Health Data Research UK (Measuring and Understanding Multimorbidity using Routine Data in the UK – HDR-9006; CFC0110). The funding source had no involvement in data collection, study design, data analysis, interpretation of findings, or the decision to publish.
PY - 2021/11/13
Y1 - 2021/11/13
UR - http://www.scopus.com/inward/record.url?scp=85118865096&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85118865096&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(21)02316-3
DO - 10.1016/S0140-6736(21)02316-3
M3 - Letter
C2 - 34756204
AN - SCOPUS:85118865096
SN - 0140-6736
VL - 398
SP - 1799
EP - 1800
JO - The Lancet
JF - The Lancet
IS - 10313
ER -